Study of Antidepressant Efficacy of a selective, high affinity enkephalinergic agonist in Anxious Major Depressive Disorder (AMDD)

Study identifier:D0880C00021

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An Investigation of the Antidepressant Efficacy of a Selective, High, Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder

Medical condition

Anxious Major Depressive Disorder

Phase

Phase 2

Healthy volunteers

No

Study drug

AZD2327, Placebo

Sex

All

Actual Enrollment

22

Study type

Interventional

Age

18 Years - 65 Years

Date

Study Start Date: 01 Jan 2009
Primary Completion Date: 01 Oct 2011
Study Completion Date: 01 Oct 2011

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2012 by AstraZeneca Pharmaceuticals

Sponsors

AstraZeneca Pharmaceuticals

Collaborators

-

Inclusion and exclusion criteria